Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03796572 · ClinicalTrials.gov registry record · Phase 4

Regional Blocks for Lateral Condyle Fractures

A Phase 4 study of Pain and Fractures, Closed, sponsored by University of California, Los Angeles.

Recruiting
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT03796572 is a Phase 4 study of Pain and Fractures, Closed that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 90 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03796572, a Phase 4 study of Pain and Fractures, Closed, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the post-operative pain control in pediatric patients with closed lateral condyle fractures who undergo open reduction and percutaneous pinning. Patients will be randomized into one of two groups. Group 1 will receive an infraclavicular nerve block to the affected extremity by a fellowship trained pediatric anesthesiologist prior to surgery. Group 2 will undergo the Orthopaedic Institute of Children's (OIC) standard preoperative protocol. Post-operative pain management will be the same for both groups per standard protocol. Pain level will be assessed post-operatively using the Wong-Baker FACES scale and parents will be asked to fill out a questionnaire regarding their satisfaction with the surgery and pain control. Parents will also fill out a medication log until the patient no longer requires pain medication. All patients in both groups will receive standard oxycodone solution prescriptions post-operatively as per typical protocol. The duration of participation in the study is approximately 1 week and requires 2 visits (time of recruitment at surgery and 1st post-op visit). This study is being conducted in hopes of developing comprehensive pain management protocols to reduce opioid consumption after surgical fixations of displaced lateral condyle fractures if the study can show that patients are more satisfied and require less opioid medication when receiving preoperative regional anesthesia.

Interventions

  • DRUG Ropivacaine
  • OTHER Puncture Wound and Dressing

Study Locations (1)

California

  • Orthopaedic Institute for Children - Los Angeles

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-09-16
Est. Completion 2027-03-07
Phase Phase 4

What the Registry Record Tells You About NCT03796572

The ClinicalTrials.gov registry entry for NCT03796572 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (70% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine is the first listed.

NCT03796572 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03796572 about?

NCT03796572 is a clinical study titled "Regional Blocks for Lateral Condyle Fractures". The purpose of this study is to investigate the post-operative pain control in pediatric patients with closed lateral condyle fractures who undergo open reduction and percutaneous pinning. Patients will be randomized into one of two groups. Group 1 will receive an infraclavicular nerve block to the ...

What is the current status of trial NCT03796572?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2019-09-16. Estimated completion is 2027-03-07.

What conditions does trial NCT03796572 study?

This clinical trial studies the following conditions: Pain, Fractures, Closed, Humeral Fractures.

What interventions are being tested in trial NCT03796572?

The interventions under investigation include: Ropivacaine (DRUG), Puncture Wound and Dressing (OTHER).

Who is sponsoring clinical trial NCT03796572?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03796572 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.